Chiropractors in Dayton, TX Accepting Medicare
4 Chiropractors found. Showing 1 - 4
 Dayton Chiropractic Center Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 113 S Main St, Dayton, TX 77535 Phone: 936-258-2789 |
Simmons Chiropractic And Wellness Center, P.c. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 108 Sterling, Dayton, TX 77535 Phone: 936-258-5020 Fax: 936-257-8565 |
 Dr. Jimmy Allen Simmons, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 108 Sterling St, Dayton, TX 77535 Phone: 936-258-5020 Fax: 936-257-8565 |
 Dr. Bobbie Bennett, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 113 S Main St, Dayton, TX 77535 Phone: 936-258-2789 Fax: 936-258-8535 |
News Archive
Nurse staffing levels, safety net status both factors in patient outcomes
A new study finds that higher nurse staffing levels can lead to better patient outcomes. However, the study also found this to not always be the case at safety net hospitals. Meanwhile, the Connecticut Mirror reports on hospitals' efforts to reduce readmissions. And, in other news, new research has found that patients are less likely to fill prescriptions when doctors specify brand names instead of allowing generic substitutions.
Stress related pathway instrumental in controlling function of immune cells
The immune system is composed of a wide range of different immune cells each with dedicated functions. Natural killer T cells form a specialized immune cell that protects against a variety of diseases such as cancer, autoimmunity, metabolic disease or certain infections such as Lyme disease.
Essential Pharmaceuticals to commence sales of cell media products acquired from Lifeblood Medical
Essential Pharmaceuticals, LLC, a private company dedicated to providing specialty reagents and solutions to the life sciences market, announced today that the Company will commence sales and distribution of three distinct animal-component-free products: serum replacement, cryopreservation and clinical pathology media, formerly sold under the LiforCell® name.
Use of anticoagulant does not reduce ischemic events among patients undergoing PCI
Use of the novel anticoagulant otamixaban did not reduce ischemic events compared with unfractionated heparin plus eptifibatide but increased bleeding among patients with non-ST-segment elevation acute coronary syndromes undergoing a percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries), according to a study published by JAMA.
New model for understanding how autism is acquired
A new model for understanding how autism is acquired has been developed by a team of researchers led by Cold Spring Harbor Laboratory (CSHL) and Albert Einstein College of Medicine.
› Verified 5 days ago
Chiropractors
Optometrists
Speech-Language Pathologists
Physical Therapists